DanPaulZandbergMD

Oncology • Pittsburgh, PA

Assistant Professor, Medicine, University of Maryland School of Medicine

Join to view full profile

Dr. Zandberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zandberg's full profile

Already have an account?

Office
5115 Centre Avenue
Pittsburgh, PA 15232
Phone+1 412-641-1000

Fax+1 412-641-1221

Education & Training

University of MarylandFellowship, Hematology and Medical Oncology, 2009 - 2012
George Washington UniversityResidency, Internal Medicine, 2005 - 2008
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005

Certifications & Licensure

PA State Medical License 2018 - 2024
MD State Medical License 2012 - 2019
VA State Medical License 2005 - 2010
DC State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
Completed
Phase 2
Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Oct 23
Completed
Phase 2
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Start of enrollment: 2019 Jan 10
Active, not recruiting
Phase 2
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies Start of enrollment: 2020 Sep 14
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the h...
Dan P Zandberg, Serafettin Zenkin, Murat Ak, Priyadarshini Mamindla, Vishal Peddagangireddy
Head & Neck. 2025-01-01
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma Patients.
Ronan W Hsieh, William E Gooding, Marci Nilsen, Mark Kubik, Zahra Kelly
Clinical Otolaryngology. 2025-01-01
The interdependence of depressive symptoms and sleep in dyads affected by cancer.
George N Diamantis, Youngmee Kim, Zoe Ofori-Atta, LaNita Devine, Michael H Antoni
Health Psychology. 2024-11-25

Journal Articles

Intratumor Genetic Heterogeneity in Squamous Cell Carcinoma of the Oral Cavity
Scott E Strome, John C Papadimitriou, Dan P Zandberg, Head & Neck

Lectures

Definitive cetuximab-based (CRT-CX) vs. non-cetuximab based chemoradiation (CRT) in older patients with squamous cell carcinoma of the head and neck (HNSCC): Analysis ...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical StudyJanuary 28th, 2021
Hill Day Advocates Present Unified Voice in Support of NIH, NCI FundingMay 1st, 2019
Taking Treatment & a Half Marathon, Together, One Step at A TimeOctober 2nd, 2017
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member